PROTAC Aster-A degrader-1
PROTAC Aster-A degrader-1 is a PROTAC degrader targeting the sterol transporter (Aster-A), with a DC50 of 4.8 μM. PROTAC Aster-A degrader-1 binds to the sterol-binding domain of Aster-A, with a FI-Kd value of 83 nM. PROTAC Aster-A degrader-1 induces CRL- and proteasome-dependent degradation of Aster-A and inhibits autophagy in cancer cells. PROTAC Aster-A degrader-1 serves as a fluorescent probe. PROTAC Aster-A degrader-1 is useful for research related to cervical cancer, breast cancer, and lung adenocarcinoma.
(Pink: Aster-A ligand (HY-128340); Blue: Cereblon ligand (HY-10984); Black: linker (HY-W442085)).
For research use only. We do not sell to patients.
- CAS No.: 3038774-43-2
- Formula: C42H51N7O10S
- Molecular Weight:845.96
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Aster-A 4.8 μM (DC50) |
In Vitro
PROTAC Aster-A degrader-1 (Compound NGF3) serves as a turn-on fluorescent probe for Aster-A, with a FI-Kd value of 83 nM[1].
PROTAC Aster-A degrader-1 binds tightly to Aster-A with a Kd of 90 nM, as determined by FP assay[1].
PROTAC Aster-A degrader-1 is suitable as a fluorescent probe in biophysical assays, with an optimal concentration of 100 nM for competitive assays[1].
PROTAC Aster-A degrader-1 (10 µM; 1 h) is cell-permeable, as shown by fluorescence in HeLa cells[1].
PROTAC Aster-A degrader-1 (0-20 µM; 18 hours) degrades Aster-A in HeLa cells with a DC50 of 4.8 µM and a Dmax of 60%[1].
PROTAC Aster-A degrader-1 does not degrade Aster-A in A549 or MCF7-eGFP-LC3 cells, indicating that its activity is cell line-dependent[1].
PROTAC Aster-A degrader-1 (3 µM) inhibits autophagy in MCF7-eGFP-LC3 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HeLa cells
-
Concentration:10 µM
-
Incubation Time:1 h
-
Result:Showed intracellular fluorescence.
-
Cell Line:HeLa cells
-
Concentration:0, 1.3, 2.5, 5, 10 and 20 µM
-
Incubation Time:18 h
-
Result:Degraded Aster-A in a dose-dependent manner, with an approximate reduction of 50% at 10 µM, a DC50 of 4.8 µM, and a Dmax of 60%.
Chemical Information
-
CAS No. 3038774-43-2
-
Molecular Weight 845.96
-
Formula C42H51N7O10S
-
SMILES
O=C(NC1=NC2=C(CN(C(OC(C)(C)C)=O)CC2)S1)C3=CC=C(C(NCCCOCCCCOCCCNC4=CC=CC5=C4C(N(C6CCC(NC6=O)=O)C5=O)=O)=O)C=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)